EduBourseActualitésCancer Research UK Relocates Data and Applications with Interxion

Cancer Research UK Relocates Data and Applications with Interxion

Pierre Perrin-Monlouis Dernière mise à jour: 20 octobre 2021

Interxion, a leading European provider of carrier-neutral colocation data centre services, today announced that Cancer Research UK, the world’s leading charity dedicated to beating cancer through research, is locating its mission-critical data and applications in Interxion’s London data centre.

Cancer Research UK spent £355 million on research in 2008/09, funding the work of 4,800 world-class scientists, doctors and nurses. The IT department’s core purpose is to enable Cancer Research UK to beat cancer through the provision of world class information tools, IT systems and services.

In 2008 the charity took the decision to outsource its data centre requirements after having compared the cost of retrofitting its own legacy data centre to using different types of colocation facilities. Early on the company realised that significant cost savings could be made by colocating its IT infrastructure with a specialist carrier-neutral operator. Interxion was chosen after a tender process in which all the colocation providers within the M25, that had both the space required and the ability to deliver within a set timescale, were invited to participate.

“The selection of Interxion and its secure robust environment, will meet our goals by improving the quality and delivery of many of our end-to-end IT services and driving down the cost.” said Jane Swindle, IS Business Change Manager at Cancer Research UK.

“It is great to see how the service we offer can generate operational benefits as well as savings for such an important worldwide organisation,” said Greg McCulloch, MD of Interxion UK. “The fact that Cancer Research UK has entrusted us with its most valuable assets is a resounding endorsement of Interxion’s leading security environment and robust infrastructure.”

– ENDS –

About Cancer Research UK
Cancer Research UK is the world’s leading charity dedicated to beating cancer through research. The charity’s groundbreaking work into the prevention, diagnosis and treatment of cancer has helped save millions of lives. This work is funded entirely by the public. Cancer Research UK has been at the heart of the progress that has already seen survival rates double in the last thirty years. Cancer Research UK supports research into all aspects of cancer through the work of more than 4,800 scientists, doctors and nurses. Together with its partners and supporters, Cancer Research UK’s vision is to beat cancer.

For further information about Cancer Research UK’s work or to find out how to support the charity, please call 020 7121 6699 or visit

About Interxion
Interxion is a leading provider of carrier-neutral colocation data centre services in Europe, serving over 1,100 customers through 26 data centres in 11 European countries. Interxion’s uniformly-designed, energy-efficient data centres offer customers extensive security and uptime for their mission-critical applications. With connectivity provided by 350 carriers and ISPs and 18 European Internet exchanges across its footprint, Interxion has created content and connectivity hubs which foster growing customer communities of interest.

For more information please visit

Press enquiries:

Ali Moinuddin
Marketing Director
Interxion Ltd
Tel: +44 207 375 7038
E-mail: [email protected]

Jared Foley / Clodagh Boyle
Spreckley Partners Ltd.
Tel: + 44 207 388 9988
E-mail: [email protected] / [email protected]

Pierre Perrin-Monlouis
Pierre Perrin-Monlouis
Fondateur de Rente et Patrimoine (cabinet de gestion de patrimoine), Pierre Perrin-Monlouis est un analyste et trader pour compte propre. Il vous fait profiter de son expérience en trading grâce à ses analyses financières et décrypte pour vous les actualités des marchés. Son approche globale des marchés combine à la fois l'analyse technique et l'analyse fondamentale sur l'ensemble des marchés : crypto, forex, actions et matières premières.